We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current RVVTF market cap is 2.55M. The company's latest EPS is CAD -0.0134 and P/E is -5.97.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.47M | -16.19M | -16.53M | -4.97M | -5.63M |
| Net Income | -5.38M | -20.12M | -17.81M | -6.32M | -5.62M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 8.26M | 29.81M | 17.07M | 14.25M | 10.64M |
| Total Liabilities | 831k | 999k | 4.46M | 3.6M | 3.4M |
| Total Equity | 7.43M | 28.81M | 12.6M | 10.65M | 7.23M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -2.52M | -8.31M | -13.06M | -6.03M | -3.29M |
| Investing | 142k | -2.72M | N/A | N/A | N/A |
| Financing | 3.28M | 26.25M | 376k | 4.2M | 1.98M |
| Market Cap | 2.55M |
| Price to Earnings Ratio | -5.97 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 44.44 |
| Price to Book Ratio | 4.63 |
| Dividend Yield | - |
| Shares Outstanding | 418.56M |
| Average Volume (1 week) | 108.77k |
| Average Volume (1 Month) | 394.67k |
| 52 Week Change | -75.20% |
| 52 Week High | 0.036 |
| 52 Week Low | 0.005 |
| Spread (Intraday) | 0.01 (88.33%) |
| Company Name | Revive Therapeutics Ltd (QB) |
| Address |
82 richmond street east toronto, ontario M5C 1P1 |
| Website | https://www.revivethera.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
